BioNxt Solutions Inc. (CVE:BNXT) | WebDisclosure

Basculer en Français

10066	Companies
205769	Keywords
136028	Articles
109101	Press releases

Headlines Articles Press releases BioNxt Solutions Inc.

Home
Companies
BioNxt Solutions Inc.

PRESS RELEASE

published on 09/09/2024 at 22:30, 1 year 6 months ago

BioNxt Receives Positive International Examination Report From the European Patent Office for Broad Patent Application for Sublingual Delivery of Anticancer Drugs for the Treatment of Autoimmune Neurodegenerative Diseases
BioNxt Solutions Inc. receives positive international examination report from the European Patent Office for sublingual delivery patent application. Company to expand patent portfolio for neurodegenerative diseases and MS market

BioNxt Solutions Inc. Multiple Sclerosis Patent Application Neurodegenerative Diseases European Patent Office
BRIEF

published on 08/15/2024 at 09:10, 1 year 7 months ago

BioNxt Signs Letter of Intent with Gen-Plus GmbH & Co KG for Potential Business Collaborations

Partnership Cladribine Pharmaceutical Development BioNxt Solutions Gen-Plus GmbH
BRIEF

published on 08/15/2024 at 09:10, 1 year 7 months ago

BioNxt signe une lettre d'intention avec Gen-Plus GmbH & Co KG pour d'éventuelles collaborations commerciales

Partenariat Cladribine Développement Pharmaceutique Solutions BioNxt Gen-Plus GmbH
PRESS RELEASE

published on 08/15/2024 at 09:05, 1 year 7 months ago

BioNxt Signs Letter of Intent with Gen-Plus GmbH & Co KG for Potential Business Collaborations
BioNxt Solutions Inc. signs non-binding LOI with Gen-Plus GmbH & Co KG, part of Conscio Group, for potential cooperation in pharmaceutical products and clinical trials. Details to follow

Clinical Trials Pharmaceutical BioNxt Solutions Inc. LOI Gen-Plus GmbH
BRIEF

published on 07/17/2024 at 09:10, 1 year 8 months ago

BioNxt Signs Statement of Work with International CRDMO for Cladribine ODF Development

Multiple Sclerosis Pharmaceutical Development BioNxt Solutions Cladribine ODF CRDMO
BRIEF

published on 07/17/2024 at 09:10, 1 year 8 months ago

BioNxt signe une déclaration de travail avec le CRDMO international pour le développement de la cladribine ODF

Sclérose En Plaques Développement Pharmaceutique Solutions BioNxt Cladribine ODF CRDMO
PRESS RELEASE

published on 07/17/2024 at 09:05, 1 year 8 months ago

BioNxt Signs Statement of Work with International Contract Research, Development, And Manufacturing Organization for Cladribine ODF Development
BioNxt Solutions Inc. signs agreement with German CRDMO for Cladribine oral dissolvable film development program targeting the lucrative multiple sclerosis market

BioNxt Solutions Inc. Cladribine CRDMO Oral Dissolvable Film MS Market
BRIEF

published on 07/09/2024 at 09:10, 1 year 8 months ago

BioNxt Signs Master Services Agreement with International Contract Research, Development, and Manufacturing Organization

Drug Development Pharmaceutical Market Master Services Agreement BioNxt Solutions Cladribine ODF
BRIEF

published on 07/09/2024 at 09:10, 1 year 8 months ago

BioNxt signe un accord-cadre de services avec une organisation internationale de recherche, de développement et de fabrication sous contrat

Marché Pharmaceutique Développement De Médicaments Solutions BioNxt Cladribine ODF Contrat-cadre De Services
PRESS RELEASE

published on 07/09/2024 at 09:05, 1 year 8 months ago

BioNxt Signs Master Services Agreement with International Contract Research, Development, and Manufacturing Organization
BioNxt Solutions Inc. signs master services agreement with German-based CRDMO for product development of oral dissolvable drug formulations

BioNxt Solutions Inc. Product Development Master Services Agreement CRDMO Oral Dissolvable Drug Formulations

Accesswire

Published on 03/23/2026 at 14:05, 1 hour 47 minutes ago

Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Published on 03/23/2026 at 14:00, 1 hour 52 minutes ago

BlackBerry AtHoc Advances Command Center for Faster Response and Tighter Control During Critical Operations
Published on 03/23/2026 at 13:05, 2 hours 47 minutes ago

SouthGobi Announces Disclosable and Connected Transaction Deferral of Payment Obligations Under Convertible Debenture and Amended and Restated Cooperation Agreement
Published on 03/23/2026 at 12:32, 3 hours 20 minutes ago

Sinopec Announced 2025 Annual Results Annual Payout Ratio Reached 81%
Published on 03/23/2026 at 12:30, 3 hours 22 minutes ago

Digi Power X to Announce 2025 Year End Financial Results on March 31st

View all ACCESSWIRE

EQS Group

Published on 03/23/2026 at 15:05, 46 minutes ago

Heidrick & Struggles Launches Heidrick Immersive, an AI-Enhanced Platform for Observing Leadership in Motion
Published on 03/23/2026 at 14:41, 1 hour 10 minutes ago

CEWE increases dividend for 17 consecutive years
Published on 03/23/2026 at 14:30, 1 hour 21 minutes ago

Solvias Earns EcoVadis Bronze Medal, Ranking in Top 35% of Companies for Sustainability Performance
Published on 03/23/2026 at 14:30, 1 hour 21 minutes ago

Belvilla Expands in Germany with Hambachtal Holiday Park in Oberhambach
Published on 03/23/2026 at 14:24, 1 hour 27 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc

Les Echos

Published on 03/23/2026 at 08:10, 7 hours 42 minutes ago

Entrée en négociations exclusives de cession de la participation dans Winncare
Published on 03/20/2026 at 19:00, 2 days 20 hours ago

AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 20 hours ago

AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 21 hours ago

Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 21 hours ago

Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA

View all LES ECHOS COMFI WIRE